MedTrace Logo

Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

NCT03390920 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-09-17

No results posted yet for this study

Summary

The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.

Conditions

  • Osteoarthritis
  • Tendinitis
  • Sports Injury
  • Degenerative Disc Disease
  • Degenerative Arthritis
  • Ligament Injury
  • Neuropathy
  • Pelvic Pain

Interventions

OTHER

Umbilical Allograft

The umbilical allograft is regulated by the FDA and comes from a lab that is FDA registered.

Sponsors & Collaborators

  • R3 Stem Cell

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2025-01-01
Completion
2030-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03390920 on ClinicalTrials.gov